Literature DB >> 27886935

Robotic-Assisted Left Ventricular Lead Placement.

Advay G Bhatt1, Jonathan S Steinberg2.   

Abstract

Robot-assisted left ventricular lead implantation for cardiac resynchronization therapy is a feasible and safe technique with superior visualization, dexterity, and precision to target the optimal pacing site. The technique has been associated with clinical response and beneficial reverse remodeling comparable with the conventional approach via the coronary sinus. The lack of clinical superiority and a residual high nonresponder rate suggest that the appropriate clinical role for the technique remains as rescue therapy. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Keywords:  Cardiac resynchronization therapy; Epicardial leads; Robotic

Mesh:

Year:  2017        PMID: 27886935     DOI: 10.1016/j.hfc.2016.07.008

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  3 in total

Review 1.  Innovations in Clinical Cardiac Electrophysiology: Challenges and Upcoming Solutions in 2018 and Beyond.

Authors:  Vaibhav R Vaidya; Alan Sugure; Samuel J Asirvatham
Journal:  J Innov Card Rhythm Manag       Date:  2017-12-15

2.  Cardiac resynchronization therapy with intraoperative epicardial mapping via minithoracotomy: 10 years' experience.

Authors:  László Hejjel; Marianna Németh; László Melczer; Attila Kónyi
Journal:  Pacing Clin Electrophysiol       Date:  2020-11-26       Impact factor: 1.976

3.  Robotic Cardiac Surgery in Europe: Status 2020.

Authors:  Stepan Cerny; Wouter Oosterlinck; Burak Onan; Sandeep Singh; Patrique Segers; Cengiz Bolcal; Cem Alhan; Emiliano Navarra; Matteo Pettinari; Frank Van Praet; Herbert De Praetere; Jan Vojacek; Theodor Cebotaru; Paul Modi; Fabien Doguet; Ulrich Franke; Ahmed Ouda; Ludovic Melly; Ghislain Malapert; Louis Labrousse; Monica Gianoli; Alfonso Agnino; Tine Philipsen; Jean-Luc Jansens; Thierry Folliguet; Meindert Palmen; Daniel Pereda; Francesco Musumeci; Piotr Suwalski; Koen Cathenis; Jef Van den Eynde; Johannes Bonatti
Journal:  Front Cardiovasc Med       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.